Video Experimental Relacionado
Updated: Feb 19, 2026
09:07
Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
Published on: June 14, 2020
11.7K
Garcinona C inhibe la replicación del virus de la pseudorrabia a través del eje EGF/PI3K/Akt
Changjie Lv1,2,3,4, Shuang Wang1,2,3, Zhongyuan Jin1,2,3
1Key Laboratory of Animal Pathogen Infection and Immunology of Fujian Province, College of Animal Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.
Frontiers in cellular and infection microbiology
|February 18, 2026
Resumen
La garcinona C inhibe eficazmente la replicación del virus de la pseudorrabia (VRP) al dirigirse a la vía PI3K-Akt. Este compuesto natural muestra una promesa como agente terapéutico contra las infecciones por VRP tanto en cultivos celulares como en modelos animales.
Área de la Ciencia:
- Virología; Farmacología; Inmunología
Sus antecedentes:
- El virus de la pseudorrabia (VRP) representa riesgos económicos y de salud pública significativos debido a su potencial zoonótico.
- Las cepas de VRP en evolución desafían la eficacia de las vacunas y los tratamientos antivirales existentes.
- Se necesitan urgentemente nuevas estrategias terapéuticas para controlar la propagación del VRP.
Objetivo del estudio:
- Evaluar la actividad antiviral de la garcinona C contra la replicación del VRP.
- Elucidar los mecanismos moleculares subyacentes a los efectos inhibidores de la garcinona C.
- Evaluar el potencial terapéutico de la garcinona C in vivo.
Principales métodos:
- Ensayos in vitro e in vivo para evaluar la inhibición de la replicación del VRP por la garcinona C.
- Experimentos de tiempo de adición para determinar la etapa de acción antiviral.
- Secuenciación de ARN y análisis de vías KEGG para identificar genes expresados diferencialmente y vías afectadas.
- Medición de los niveles de citoquinas (IL-6, IL-8, TNF-α).
- Estudios en animales que involucran la administración oral de garcinona C a ratones infectados con VRP.
Principales resultados:
- La garcinona C inhibió la replicación del VRP de manera dependiente de la dosis y el tiempo, específicamente cuando se administró después de la infección.
- El análisis transcriptómico reveló que el efecto antiviral de la garcinona C está relacionado con la vía de señalización PI3K-Akt, potencialmente a través de la regulación negativa del factor de crecimiento epidérmico.
- La garcinona C suprimió la producción de citoquinas inflamatorias (IL-6, IL-8, TNF-α) y mejoró las tasas de supervivencia, redujo la patología y las cargas virales en ratones infectados.
Conclusiones:
- La garcinona C demuestra un potencial terapéutico significativo como agente antiviral contra el VRP.
- La vía de señalización PI3K-Akt es un objetivo clave para el mecanismo de acción de la garcinona C contra el VRP.
- La garcinona C representa un candidato prometedor para el desarrollo de nuevos tratamientos para combatir las infecciones por VRP.
Videos de Conceptos Relacionados
01:09GPCRs Regulate Adenylyl Cylase Activity
7.7K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.7K
01:20The JAK-STAT Signaling Pathway
13.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.2K
01:22PI3K/mTOR/AKT Signaling Pathway
5.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.7K
01:14Rab Proteins
5.2K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
5.2K
02:15Experimental RNAi
7.8K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.8K
01:24Small GTPases - Ras and Rho
5.5K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.5K